{"id":22892,"date":"2026-09-08T16:45:57","date_gmt":"2026-09-08T14:45:57","guid":{"rendered":"https:\/\/mic-site.labiux.com\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/"},"modified":"2026-09-08T16:45:57","modified_gmt":"2026-09-08T14:45:57","slug":"eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/","title":{"rendered":"&#8220;Eurostat&#8221;: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>Latvij\u0101 2025. gad\u0101 aptauko\u0161an\u0101s bija 24,6% iedz\u012bvot\u0101ju vecum\u0101 no 18 gadiem, kas ir otrs augst\u0101kais r\u0101d\u012bt\u0101js Eiropas Savien\u012bb\u0101 (ES), liecina jaun\u0101kie ES statistikas biroja &#8220;Eurostat&#8221; dati.<\/p>\n<p>Augst\u0101ks aptauko\u0161an\u0101s \u012bpatsvars re\u0123istr\u0113ts tikai Malt\u0101, kur tas sasniedza 26,6%. Savuk\u0101rt tre\u0161ais augst\u0101kais r\u0101d\u012bt\u0101js bija Somij\u0101 &#8211; 23,2%.<\/p>\n<p>Latvij\u0101 aptauko\u0161an\u0101s \u012bpatsvars par 8,3 procentpunktiem p\u0101rsniedza ES vid\u0113jo r\u0101d\u012bt\u0101ju. Kopum\u0101 ES aptauko\u0161an\u0101s 2025. gad\u0101 bija 16,3% pieaugu\u0161o.<\/p>\n<p>Viszem\u0101kais aptauko\u0161an\u0101s \u012bpatsvars re\u0123istr\u0113ts It\u0101lij\u0101, kur tas bijis 7%. Savuk\u0101rt Grie\u0137ij\u0101 \u0161is \u012bpatsvars bijis 12,8% un Rum\u0101nij\u0101 &#8211; 12,9%.<\/p>\n<p>&#8220;Eurostat&#8221; dati liecina, ka 35,4% ES iedz\u012bvot\u0101ju p\u0113rn bija liekais svars, bet \u0137erme\u0146a masas indekss v\u0113l nesasniedza aptauko\u0161an\u0101s slieksni. T\u0101d\u0113j\u0101di kopum\u0101 51,7% jeb vair\u0101k nek\u0101 pusei pieaugu\u0161o ES bija liekais svars vai aptauko\u0161an\u0101s.<\/p>\n<p>V\u012brie\u0161iem liekais svars konstat\u0113ts bie\u017e\u0101k nek\u0101 sieviet\u0113m. Aptauko\u0161an\u0101s konstat\u0113ta 17,4% v\u012brie\u0161u un 15,3% sievie\u0161u, savuk\u0101rt \u0137erme\u0146a masas indekss robe\u017e\u0101s no 25 l\u012bdz 30 bija 41,9% v\u012brie\u0161u un 29,3% sievie\u0161u. Turpret\u012b nepietiekams svars bija 2,9% sievie\u0161u un 1% v\u012brie\u0161u.<\/p>\n<p>Aptauko\u0161anos nosaka p\u0113c \u0137erme\u0146a masas indeksa, ko apr\u0113\u0137ina, svaru kilogramos dalot ar auguma garuma metros kvadr\u0101tu. Par aptauko\u0161anos uzskata \u0137erme\u0146a masas indeksu, kas sasniedzis vismaz 30, savuk\u0101rt indekss no 25 l\u012bdz 30 nor\u0101da uz lieko svaru. Nepietiekams svars ir cilv\u0113kiem, kuru \u0137erme\u0146a masas indekss ir maz\u0101ks par 18,5.<\/p>\n<p>Aptauko\u0161an\u0101s \u012bpatsvars ir viens no r\u0101d\u012bt\u0101jiem, ko izmanto, v\u0113rt\u0113jot progresu ANO ilgtsp\u0113j\u012bgas att\u012bst\u012bbas m\u0113r\u0137u sasnieg\u0161an\u0101 uztura, vesel\u012bbas un labkl\u0101j\u012bbas jom\u0101.<\/p>\n<p>Jau v\u0113st\u012bts, ka pag\u0101ju\u0161\u0101 gada oktobr\u012b vald\u012bba apstiprin\u0101ja Vesel\u012bbas ministrijas (VM) izstr\u0101d\u0101to r\u012bc\u012bbas pl\u0101nu liek\u0101 svara un aptauko\u0161an\u0101s izplat\u012bbas pieauguma mazin\u0101\u0161anai 2025. l\u012bdz 2029. gadam, kura m\u0113r\u0137is ir aptur\u0113t liek\u0101 svara un aptauko\u0161an\u0101s pieaugumu Latvijas sabiedr\u012bb\u0101, mazinot neinfekcijas slim\u012bbu att\u012bst\u012bbas risku.<\/p>\n<p>Pl\u0101n\u0101 noteikti \u010detri galvenie darb\u012bbas virzieni &#8211; vesel\u012bga uztura un fizisko aktivit\u0101\u0161u paradumu uzlabo\u0161ana, riska grupu agr\u012bna atpaz\u012b\u0161ana, aptauko\u0161an\u0101s diagnostikas un \u0101rst\u0113\u0161anas uzlabo\u0161ana, k\u0101 ar\u012b \u012bstenoto pas\u0101kumu efektivit\u0101tes izv\u0113rt\u0113\u0161ana.<\/p>\n<p>Dokumenta ilgtermi\u0146a m\u0113r\u0137is ir l\u012bdz 2060. gadam samazin\u0101t liek\u0101 svara un aptauko\u0161an\u0101s izplat\u012bbu pieaugu\u0161o vid\u016b l\u012bdz 45,1% un pagarin\u0101t vesel\u012bgi nodz\u012bvot\u0101 m\u016b\u017ea ilgumu l\u012bdz 72,8 gadiem.<\/p>\n<p>VM nor\u0101d\u012bjusi, ka vesel\u012bgi nodz\u012bvot\u0101 m\u016b\u017ea ilgums Latvij\u0101 ir tikai 54,2 gadi, kas ir viens no zem\u0101kajiem r\u0101d\u012bt\u0101jiem ES, savuk\u0101rt liekais svars vai aptauko\u0161an\u0101s konstat\u0113ta gandr\u012bz 60% iedz\u012bvot\u0101ju vecum\u0101 no 15 l\u012bdz 74 gadiem.<\/p>\n<p>Avots: LETA<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Latvij\u0101 2025. gad\u0101 aptauko\u0161an\u0101s bija 24,6% iedz\u012bvot\u0101ju vecum\u0101 no 18 gadiem, kas ir otrs augst\u0101kais r\u0101d\u012bt\u0101js Eiropas Savien\u012bb\u0101 (ES), liecina jaun\u0101kie ES statistikas biroja &#8220;Eurostat&#8221; dati. Augst\u0101ks aptauko\u0161an\u0101s \u012bpatsvars re\u0123istr\u0113ts [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[71,76,7],"tags":[1227],"mic_flag":[],"class_list":["post-22892","post","type-post","status-publish","format-standard","hentry","category-interesanti-fakti","category-jaunakie-raksti","category-statistika","tag-aptaukosanas"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Latvij\u0101 2025. gad\u0101 aptauko\u0161an\u0101s bija 24,6% iedz\u012bvot\u0101ju vecum\u0101 no 18 gadiem, kas ir otrs augst\u0101kais r\u0101d\u012bt\u0101js Eiropas Savien\u012bb\u0101 (ES), liecina jaun\u0101kie ES statistikas biroja &quot;Eurostat&quot; dati. Augst\u0101ks aptauko\u0161an\u0101s \u012bpatsvars re\u0123istr\u0113ts tikai Malt\u0101, kur tas sasniedza 26,6%. Savuk\u0101rt tre\u0161ais augst\u0101kais r\u0101d\u012bt\u0101js bija Somij\u0101 - 23,2%. Latvij\u0101 aptauko\u0161an\u0101s \u012bpatsvars par 8,3 procentpunktiem p\u0101rsniedza ES vid\u0113jo r\u0101d\u012bt\u0101ju. Kopum\u0101\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u201cEurostat\u201d: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101 - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Latvij\u0101 2025. gad\u0101 aptauko\u0161an\u0101s bija 24,6% iedz\u012bvot\u0101ju vecum\u0101 no 18 gadiem, kas ir otrs augst\u0101kais r\u0101d\u012bt\u0101js Eiropas Savien\u012bb\u0101 (ES), liecina jaun\u0101kie ES statistikas biroja &quot;Eurostat&quot; dati. Augst\u0101ks aptauko\u0161an\u0101s \u012bpatsvars re\u0123istr\u0113ts tikai Malt\u0101, kur tas sasniedza 26,6%. Savuk\u0101rt tre\u0161ais augst\u0101kais r\u0101d\u012bt\u0101js bija Somij\u0101 - 23,2%. Latvij\u0101 aptauko\u0161an\u0101s \u012bpatsvars par 8,3 procentpunktiem p\u0101rsniedza ES vid\u0113jo r\u0101d\u012bt\u0101ju. Kopum\u0101\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-08T14:45:57+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-08T14:45:57+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u201cEurostat\u201d: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101 - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Latvij\u0101 2025. gad\u0101 aptauko\u0161an\u0101s bija 24,6% iedz\u012bvot\u0101ju vecum\u0101 no 18 gadiem, kas ir otrs augst\u0101kais r\u0101d\u012bt\u0101js Eiropas Savien\u012bb\u0101 (ES), liecina jaun\u0101kie ES statistikas biroja &quot;Eurostat&quot; dati. Augst\u0101ks aptauko\u0161an\u0101s \u012bpatsvars re\u0123istr\u0113ts tikai Malt\u0101, kur tas sasniedza 26,6%. Savuk\u0101rt tre\u0161ais augst\u0101kais r\u0101d\u012bt\u0101js bija Somij\u0101 - 23,2%. Latvij\u0101 aptauko\u0161an\u0101s \u012bpatsvars par 8,3 procentpunktiem p\u0101rsniedza ES vid\u0113jo r\u0101d\u012bt\u0101ju. Kopum\u0101\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"name\":\"Statistika\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"position\":2,\"name\":\"Statistika\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\\\/#listItem\",\"name\":\"&#8220;Eurostat&#8221;: Latvij\\u0101 p\\u0113rn bijis otrs augst\\u0101kais aptauko\\u0161an\\u0101s \\u012bpatsvars Eiropas Savien\\u012bb\\u0101\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\\\/#listItem\",\"position\":3,\"name\":\"&#8220;Eurostat&#8221;: Latvij\\u0101 p\\u0113rn bijis otrs augst\\u0101kais aptauko\\u0161an\\u0101s \\u012bpatsvars Eiropas Savien\\u012bb\\u0101\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"name\":\"Statistika\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\\\/#newsarticle\",\"name\":\"\\u201cEurostat\\u201d: Latvij\\u0101 p\\u0113rn bijis otrs augst\\u0101kais aptauko\\u0161an\\u0101s \\u012bpatsvars Eiropas Savien\\u012bb\\u0101 - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"&#8220;Eurostat&#8221;: Latvij\\u0101 p\\u0113rn bijis otrs augst\\u0101kais aptauko\\u0161an\\u0101s \\u012bpatsvars Eiropas Savien\\u012bb\\u0101\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"datePublished\":\"2026-09-08T16:45:57+03:00\",\"dateModified\":\"2026-09-08T16:45:57+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\\\/#webpage\"},\"articleSection\":\"Interesanti, Jaun\\u0101kie raksti, Statistika, aptauko\\u0161an\\u0101s\",\"dateline\":\"Published on September 8, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\\\/\",\"name\":\"\\u201cEurostat\\u201d: Latvij\\u0101 p\\u0113rn bijis otrs augst\\u0101kais aptauko\\u0161an\\u0101s \\u012bpatsvars Eiropas Savien\\u012bb\\u0101 - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Latvij\\u0101 2025. gad\\u0101 aptauko\\u0161an\\u0101s bija 24,6% iedz\\u012bvot\\u0101ju vecum\\u0101 no 18 gadiem, kas ir otrs augst\\u0101kais r\\u0101d\\u012bt\\u0101js Eiropas Savien\\u012bb\\u0101 (ES), liecina jaun\\u0101kie ES statistikas biroja \\\"Eurostat\\\" dati. Augst\\u0101ks aptauko\\u0161an\\u0101s \\u012bpatsvars re\\u0123istr\\u0113ts tikai Malt\\u0101, kur tas sasniedza 26,6%. Savuk\\u0101rt tre\\u0161ais augst\\u0101kais r\\u0101d\\u012bt\\u0101js bija Somij\\u0101 - 23,2%. Latvij\\u0101 aptauko\\u0161an\\u0101s \\u012bpatsvars par 8,3 procentpunktiem p\\u0101rsniedza ES vid\\u0113jo r\\u0101d\\u012bt\\u0101ju. Kopum\\u0101\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"datePublished\":\"2026-09-08T16:45:57+03:00\",\"dateModified\":\"2026-09-08T16:45:57+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"\u201cEurostat\u201d: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101 - Medikamentu Inform\u0101cijas Centrs","description":"Latvij\u0101 2025. gad\u0101 aptauko\u0161an\u0101s bija 24,6% iedz\u012bvot\u0101ju vecum\u0101 no 18 gadiem, kas ir otrs augst\u0101kais r\u0101d\u012bt\u0101js Eiropas Savien\u012bb\u0101 (ES), liecina jaun\u0101kie ES statistikas biroja \"Eurostat\" dati. Augst\u0101ks aptauko\u0161an\u0101s \u012bpatsvars re\u0123istr\u0113ts tikai Malt\u0101, kur tas sasniedza 26,6%. Savuk\u0101rt tre\u0161ais augst\u0101kais r\u0101d\u012bt\u0101js bija Somij\u0101 - 23,2%. Latvij\u0101 aptauko\u0161an\u0101s \u012bpatsvars par 8,3 procentpunktiem p\u0101rsniedza ES vid\u0113jo r\u0101d\u012bt\u0101ju. Kopum\u0101","canonical_url":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","name":"Statistika"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","position":2,"name":"Statistika","item":"https:\/\/farmacija-mic.lv\/category\/statistika\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/#listItem","name":"&#8220;Eurostat&#8221;: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/#listItem","position":3,"name":"&#8220;Eurostat&#8221;: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","name":"Statistika"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/#newsarticle","name":"\u201cEurostat\u201d: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101 - Medikamentu Inform\u0101cijas Centrs","headline":"&#8220;Eurostat&#8221;: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"datePublished":"2026-09-08T16:45:57+03:00","dateModified":"2026-09-08T16:45:57+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/#webpage"},"articleSection":"Interesanti, Jaun\u0101kie raksti, Statistika, aptauko\u0161an\u0101s","dateline":"Published on September 8, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/","name":"\u201cEurostat\u201d: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101 - Medikamentu Inform\u0101cijas Centrs","description":"Latvij\u0101 2025. gad\u0101 aptauko\u0161an\u0101s bija 24,6% iedz\u012bvot\u0101ju vecum\u0101 no 18 gadiem, kas ir otrs augst\u0101kais r\u0101d\u012bt\u0101js Eiropas Savien\u012bb\u0101 (ES), liecina jaun\u0101kie ES statistikas biroja \"Eurostat\" dati. Augst\u0101ks aptauko\u0161an\u0101s \u012bpatsvars re\u0123istr\u0113ts tikai Malt\u0101, kur tas sasniedza 26,6%. Savuk\u0101rt tre\u0161ais augst\u0101kais r\u0101d\u012bt\u0101js bija Somij\u0101 - 23,2%. Latvij\u0101 aptauko\u0161an\u0101s \u012bpatsvars par 8,3 procentpunktiem p\u0101rsniedza ES vid\u0113jo r\u0101d\u012bt\u0101ju. Kopum\u0101","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"datePublished":"2026-09-08T16:45:57+03:00","dateModified":"2026-09-08T16:45:57+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"\u201cEurostat\u201d: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101 - Medikamentu Inform\u0101cijas Centrs","og:description":"Latvij\u0101 2025. gad\u0101 aptauko\u0161an\u0101s bija 24,6% iedz\u012bvot\u0101ju vecum\u0101 no 18 gadiem, kas ir otrs augst\u0101kais r\u0101d\u012bt\u0101js Eiropas Savien\u012bb\u0101 (ES), liecina jaun\u0101kie ES statistikas biroja &quot;Eurostat&quot; dati. Augst\u0101ks aptauko\u0161an\u0101s \u012bpatsvars re\u0123istr\u0113ts tikai Malt\u0101, kur tas sasniedza 26,6%. Savuk\u0101rt tre\u0161ais augst\u0101kais r\u0101d\u012bt\u0101js bija Somij\u0101 - 23,2%. Latvij\u0101 aptauko\u0161an\u0101s \u012bpatsvars par 8,3 procentpunktiem p\u0101rsniedza ES vid\u0113jo r\u0101d\u012bt\u0101ju. Kopum\u0101","og:url":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/","article:published_time":"2026-09-08T14:45:57+00:00","article:modified_time":"2026-09-08T14:45:57+00:00","twitter:card":"summary_large_image","twitter:title":"\u201cEurostat\u201d: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101 - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Latvij\u0101 2025. gad\u0101 aptauko\u0161an\u0101s bija 24,6% iedz\u012bvot\u0101ju vecum\u0101 no 18 gadiem, kas ir otrs augst\u0101kais r\u0101d\u012bt\u0101js Eiropas Savien\u012bb\u0101 (ES), liecina jaun\u0101kie ES statistikas biroja &quot;Eurostat&quot; dati. Augst\u0101ks aptauko\u0161an\u0101s \u012bpatsvars re\u0123istr\u0113ts tikai Malt\u0101, kur tas sasniedza 26,6%. Savuk\u0101rt tre\u0161ais augst\u0101kais r\u0101d\u012bt\u0101js bija Somij\u0101 - 23,2%. Latvij\u0101 aptauko\u0161an\u0101s \u012bpatsvars par 8,3 procentpunktiem p\u0101rsniedza ES vid\u0113jo r\u0101d\u012bt\u0101ju. Kopum\u0101"},"aioseo_meta_data":{"post_id":"22892","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-16 20:25:05","updated":"2026-10-16 20:25:05"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/statistika\/\" title=\"Statistika\">Statistika<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t\u201cEurostat\u201d: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Statistika","link":"https:\/\/farmacija-mic.lv\/category\/statistika\/"},{"label":"&#8220;Eurostat&#8221;: Latvij\u0101 p\u0113rn bijis otrs augst\u0101kais aptauko\u0161an\u0101s \u012bpatsvars Eiropas Savien\u012bb\u0101","link":"https:\/\/farmacija-mic.lv\/en\/eurostat-latvija-pern-bijis-otrs-augstakais-aptaukosanas-ipatsvars-eiropas-savieniba\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=22892"}],"version-history":[{"count":0,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22892\/revisions"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=22892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=22892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=22892"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=22892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}